Use of statins to inhibit formation of osteoclasts
CA 2401319 A1 · Owner: Warner-Lambert Company · Inventors: Renkiewicz, Richard Raymond; Baragi, Vijaykumar Mahalingappa; Devalaraja, Radhika Madhav
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for inhibiting the formation of osteoclasts comprising administering a therapeutically effective amount of a statin to a mammal in need, thereof as well as pharmaceutical compositions kits for containing such, compositions comprising a statin or a method of treating or preventing a disease, state selected from the group consisting of osteoporosis Paget's disease, osteolysis, hypercalcemia of malignancy osteogenesis imperfecta, osteoarthritis alveolar bone loss, side effects of immunosuppressive therapy and side , effects of, chronic glucocorticoid use by inhibiting the formation of osteoclasts comprising, administering a therapeutically effective amount of a statin to a mammal …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 5, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 5, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 5, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.